To gain mechanistic insights into the clinical relevance of p‐TFCP2L1 in bladder carcinogenesis, we first compared the endogenous expression levels of TFCP2L1 and CDK1 between primary human bladder epithelial cells (HBlEpCs) and BC cell lines such as J82 and T24. The gene discussed is TFCP2L1; the disease is breast cancer.